Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Mader, JK; Lucarelli, F; Scuffi, C; Aberer, F; Korsatko, S; Valgimigli, F; Pieber, TR.
Optimising the glucose sampling performance of an intravascular microdialysisbased continuous glucose monitoring device for use in hospital settings.
Biomed Tech (Berl). 2013; 58 Suppl 1(1):
Doi: 10.1515/bmt-2013-4142
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Mader Julia
- Co-authors Med Uni Graz
-
Aberer Felix
-
Korsatko Stefan
-
Pieber Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Over the past years, the possibility of using Subcutaneous Continuous Glucose Monitoring (CGM) devices for monitoring hospitalised patients has been explored. However, concerns about the reliability of such CGM data, particularly for subjects whose physiopathological condition compromises the correlation between interstitial fluid and blood compartment, have been raised. CGM devices based on intravascular microdialysis may represent a solution to this problem. Aim of these trials (GMD_04 and GMD_05, which involved 20 healthy and 14 T1DM subjects, respectively) was to optimise the performance of an intravascular microdialysis-based device under development at A. Menarini Diagnostics (Italy).
- Find related publications in this database (Keywords)
-
GlucoMen (R) Day
-
CGM
-
microdialysis
-
ICU